TOM1L Is Involved in a Novel Signaling Pathway Important for the IL-2 Production in Jurkat T Cells Stimulated by CD3/CD28 CoLigation
TOM1L (target of Myb-1 Like) was identified as a binding partner for the full length and catalytically-active Lck in a yeast 2-hybrid screening assay. Here we show that in Jurkat T cells stimulated by CD3/CD28 coligation where the expression of TOM1L is reduced by lenti virus mediated-siRNA results...
Saved in:
Main Authors: | Ahmed Elmarghani (Author), Hanan Abuabaid (Author), Peter Kjellen (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2009-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lower proportion of CD19+IL-10+ and CD19+CD24+CD27+ but not CD1d+CD5+CD19+CD24+CD27+ IL-10+ B cells in children with autoimmune thyroid diseases
by: Karolina Stożek, et al.
Published: (2020) -
Inducing CCR5Δ32/Δ32 Homozygotes in the Human Jurkat CD4+ Cell Line and Primary CD4+ Cells by CRISPR-Cas9 Genome-Editing Technology
by: Chunxia Qi, et al.
Published: (2018) -
A CD3/CD28 microbead-based HIV-1 viral outgrowth assay
by: Yury V. Kuzmichev, et al.
Published: (2017) -
CD28 Aptamers as Powerful Immune Response Modulators
by: Fernando Pastor, et al.
Published: (2013) -
Enfermedad tiroidea autoinmune, ctla-4 y cd 28
by: Silvana Roveto, et al.
Published: (2010)